Image pharmaphorum Editor Oncology Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ... Researchers also dove into socio-economic disparities in cancer care. Oncology Phesi’s Dr Gen Li: New approaches to clinical trials in canc... Dr Gen Li, founder and president of Phesi, a provider of AI-powered clinical development analytics, products and solutions, discusses some of the latest challenges facing the industry, incl Oncology Realising the promise of cancer vaccines For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason. Oncology New horizons in breast cancer care Interview with Markus Kosch, Daiichi Sankyo head of Oncology Business Division in Europe. Load more results
Oncology Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ... Researchers also dove into socio-economic disparities in cancer care.
Oncology Phesi’s Dr Gen Li: New approaches to clinical trials in canc... Dr Gen Li, founder and president of Phesi, a provider of AI-powered clinical development analytics, products and solutions, discusses some of the latest challenges facing the industry, incl
Oncology Realising the promise of cancer vaccines For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason.
Oncology New horizons in breast cancer care Interview with Markus Kosch, Daiichi Sankyo head of Oncology Business Division in Europe.
News UK issues £45m funding call for research partnerships The NIHR has revealed the first £45m in funding for projects that can bridge the translation gap in healthcare, focusing initially on community care.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
